EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Transdermal microarrayed electroporation for enhanced cancer immunotherapy based on DNA vaccination

Yuan Wang iD, Jin Qu, Chuxiao Xiong iD, Bing Chen, Kai Xie, Mingxue Wang, Zhen Liu iD, Zhao Yue, Zhenghua Liang iD, Feng Wang, Tianlong Zhang, Guangyu Zhu iD und 2 weitere

Proceedings of the National Academy of Sciences · 18.06.2024 · 121 (25)

DOI: 10.1073/pnas.2322264121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 12.06.2024. Verfasst von Yuan Wang und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong Special Administrative Region 999077, China. Hauptthemen laut MEDLINE: Vaccines, DNA, Electroporation, Immunotherapy. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 53 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), General Research Fund, City University of Hong Kong (CityU).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the tremendous clinical potential of nucleic acid–based vaccines, their efficacy to induce therapeutic immune response has been limited by the lack of efficient local gene delivery techniques in the human body. In this study, we develop a hydrogel-based organic electronic device (μEPO) for both transdermal delivery of nucleic acids and in vivo microarrayed cell electroporation, which is specifically oriented toward one-step transfection of DNAs in subcutaneous antigen-presenting cells (APCs) for cancer immunotherapy. The μEPO device contains an array of microneedle-shaped electrodes with pre-encapsulated dry DNAs. Upon a pressurized contact with skin tissue, the electrodes are rehydrated, electrically triggered to release DNAs, and then electroporate nearby cells, which can achieve in vivo transfection of more than 50% of the cells in the epidermal and upper dermal layer. As a proof-of-concept, the μEPO technique is employed to facilitate transdermal delivery of neoantigen genes to activate antigen-specific immune response for enhanced cancer immunotherapy based on a DNA vaccination strategy. In an ovalbumin (OVA) cancer vaccine model, we show that high-efficiency transdermal transfection of APCs with OVA-DNAs induces robust cellular and humoral immune responses, including antigen presentation and generation of IFN-γ + cytotoxic T lymphocytes with a more than 10-fold dose sparing over existing intramuscular injection (IM) approach, and effectively inhibits tumor growth in rodent animals.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vaccines, DNAElectroporationImmunotherapyAnimalsMiceAdministration, CutaneousNeoplasmsCancer VaccinesOvalbuminAntigen-Presenting CellsFemaleMice, Inbred C57BLHumansVaccination

Stichwörter der Autor:innen

DNA vaccinationcancer immunotherapyhydrogel electronicsin vivo electroporationtransdermal gene delivery

Substanzen

Vaccines, DNACancer VaccinesOvalbumin

Autor:innen und Institutionen

  • Department of Biomedical Engineering, City University of Hong Kong, Kowloon, Hong Kong Special Administrative Region 999077, China.
  • Department of Materials Science and Engineering, City University of Hong Kong, Kowloon, Hong Kong Special Administrative Region 999077, China.
  • Department of Chemistry, City University of Hong Kong, Kowloon, Hong Kong Special Administrative Region 999077, China.
  • Department of Chemical and Biological Engineering, The Hong Kong University of Science and Technology, Kowloon, Hong Kong Special Administrative Region 999077, China.
  • Department of Mechanical and Aerospace Engineering, The Hong Kong University of Science and Technology, Hong Kong Special Administrative Region 999077, China.
  • Center of Super-Diamond and Advanced Films, City University of Hong Kong, Kowloon, Hong Kong Special Administrative Region 999077, China.

ORCID-Profile: Yuan Wang, Chuxiao Xiong, Zhen Liu, Zhenghua Liang, Guangyu Zhu, Peng Shi

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • General Research Fund
  • City University of Hong Kong (CityU)

Zitieren

APA

Wang, Y., Qu, J., Xiong, C., Chen, B., Xie, K., Wang, M., Liu, Z., Yue, Z., Liang, Z., Wang, F., Zhang, T., Zhu, G., Kuang, Y. B., & Shi, P. (2024). Transdermal microarrayed electroporation for enhanced cancer immunotherapy based on DNA vaccination. Proceedings of the National Academy of Sciences, 121(25). https://doi.org/10.1073/pnas.2322264121

Vancouver

Wang Y, Qu J, Xiong C, Chen B, Xie K, Wang M, et al. Transdermal microarrayed electroporation for enhanced cancer immunotherapy based on DNA vaccination. Proceedings of the National Academy of Sciences. 2024;121(25). doi:10.1073/pnas.2322264121

BibTeX
@article{Wang2024,
  author = {Wang, Yuan and Qu, Jin and Xiong, Chuxiao and Chen, Bing and Xie, Kai and Wang, Mingxue and Liu, Zhen and Yue, Zhao and Liang, Zhenghua and Wang, Feng and Zhang, Tianlong and Zhu, Guangyu and Kuang, Yi Becki and Shi, Peng},
  title = {Transdermal microarrayed electroporation for enhanced cancer immunotherapy based on DNA vaccination},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {25},
  doi = {10.1073/pnas.2322264121}
}
Kostenlos starten →